Equal outcomes for prostate cancer treatments
This article was originally published in Clinica
Executive Summary
Patients treated in the early stages of prostate cancer have survival rates between 85% and 95% after five years, whether they receive surgery, brachytherapy or beam radiation, according to combined data from nine European and US studies.